MRSN Competitors & Alternatives
Compare Mersana Therapeutics Inc with similar stocks in the same industry
Biotechnology
MRSN
Main Stock$29.08
Tradestie Score
56
Market Cap
$39.63M
Revenue Growth
-0.1%
Analyst Upside
+14.2%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$7.73
|
$211.22M | - | 55 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.36
|
$202.58M | - | 58 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$14.60
|
$170.45M | - | 48 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$5.60
|
$158.43M | - | 59 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.49
|
$133.50M | - | 56 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.17
|
$110.20M | - | 54 | Compare |
|
MGNX
MacroGenics, Inc.
|
$4.13
|
$107.45M | - | 59 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$30.20
|
$76.55M | - | 55 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.37
|
$71.69M | - | 59 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.47
|
$67.94M | - | 54 | Compare |
More MRSN Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry